Food News and Research

RSS

Researcher explores the use of Chinese wolfberries to improve vision deficiencies

A Kansas State University researcher is exploring the use of Chinese wolfberries to improve vision deficiencies that are common for type-2 diabetics.

31 Mar 2010

Guided Therapeutics' LightTouch Cervical Scanner demonstrates increased detection of disease over Pap tests

The Guided Therapeutics, Inc. LightTouch™ Cervical Scanner increased detection of significant disease over Pap tests in women seen in a busy private practice setting, according to results of a U.S. Food and Drug Administration pivotal clinical trial presented at the American Society for Colposcopy and Cervical Pathology biennial meeting.

31 Mar 2010

Drinking orange juice with fast-food meal may help prevent vascular inflammation

Eating foods containing flavonoids -- orange juice, in this case -- along with a high-fat, high-carbohydrate fast-food meal neutralizes the oxidative and inflammatory stress generated by the unhealthy food and helps prevent blood vessel damage, a new study by University at Buffalo endocrinologists shows.

31 Mar 2010

U.S. hotel offers personalized menus for children with food allergies

Traveling and dining with a young child with food allergies or special dietary needs can be a nightmare as most restaurants and hotels are not sensitive to this epidemic affecting more than three million children - one in 17 for those under age 3 - in the U.S. Lake Arrowhead Resort and Spa now offers personalized menus for guests' children on restricted diets to make them feel special, not different.

31 Mar 2010

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing.

From Roche Sequencing and Life Science 31 Mar 2010

Kaiser Permanente to deploy solar power systems at 15 facilities across the state

Committed to improving the health of the communities it serves, Kaiser Permanente has agreed to deploy 15 megawatts of solar power in a deal that will put solar power systems at 15 facilities across the state by the summer of 2011.

31 Mar 2010

FDA accepts filing of Lux Biosciences' NDA for Luveniq and grants application priority review

Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration has accepted the filing of the company's New Drug Application for Luveniq™ (oral voclosporin) and has granted the application priority review.

31 Mar 2010

Depomed licensee submits DM-1796 NDA for management of PHN

Depomed, Inc. today announced that its licensee has submitted a New Drug Application (NDA) for DM-1796 to the U.S. Food and Drug Administration (FDA) for the management of postherpetic neuralgia (PHN), or pain after shingles. DM-1796 is an investigational, extended release, once-daily tablet formulation of gabapentin designed to reduce dosing frequency and have a low incidence of side effects.

31 Mar 2010

Cambridge Heart's fourth-quarter total revenue down 20%

Cambridge Heart, Inc., today reported results for its fourth quarter and year ended December 31, 2009. Full financial statements and corresponding commentary can be found in the Company's Form 10-K, which is expected to be filed with the Securities and Exchange Commission on March 31, 2010.

31 Mar 2010

FDA grants priority review status for Isotechnika Pharma's voclosporin

Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.

31 Mar 2010

Bovie Medical seeks FDA marketing approval for 1450RF new high frequency electrosurgical generator

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company has applied for 510(k) clearance from the Food and Drug Administration (FDA) to market a new high frequency electrosurgical generator specifically designed for the physician office market.

31 Mar 2010

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.

31 Mar 2010

Asclera injection receives FDA approval

The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins.

31 Mar 2010

FDA issues Complete Response Letter for CERTRIAD NDA

AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.

31 Mar 2010

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Ikaria Holdings, Inc. announced today that it has acquired the New Drug Application (NDA) and the Investigational New Drug (IND) application to LUCASSIN® (terlipressin for injection) from Orphan Therapeutics, assuming all future development and ownership of the drug in North America and Australia.

31 Mar 2010

FDA allows GeoVax Labs to commence phase 1 clinical trial for HIV/AIDS therapeutic vaccine

GeoVax Labs, Inc., a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine, which is intended as a treatment for individuals infected with HIV. The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection.

30 Mar 2010

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has acknowledged receipt of and accepted for review the March 15, 2010 resubmission of the Biologics License Application for KRYSTEXXA™ (pegloticase), a treatment for chronic gout in patients refractory to conventional therapy.

30 Mar 2010

Campbell Soup honored for commitment to food allergy safety, awareness and education

Campbell Soup Company was recently honored by the Food Allergy and Anaphylaxis Network for its commitment to food allergy safety, awareness and education.

30 Mar 2010

Posting calorie counts on menus and menu boards also needed in Ontario

US President Barack Obama's groundbreaking health care legislation includes a provision requiring restaurants to post calories on menus and menu boards. For the past year, Ontario's doctors have been calling for similar action from the government, chain restaurants and school cafeterias in the province and believe now is the perfect time for this initiative to be implemented.

30 Mar 2010

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.

30 Mar 2010

Food News and Research

Researcher explores the use of Chinese wolfberries to improve vision deficiencies

Guided Therapeutics' LightTouch Cervical Scanner demonstrates increased detection of disease over Pap tests

Drinking orange juice with fast-food meal may help prevent vascular inflammation

U.S. hotel offers personalized menus for children with food allergies

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

Kaiser Permanente to deploy solar power systems at 15 facilities across the state

FDA accepts filing of Lux Biosciences' NDA for Luveniq and grants application priority review

Depomed licensee submits DM-1796 NDA for management of PHN

Cambridge Heart's fourth-quarter total revenue down 20%

FDA grants priority review status for Isotechnika Pharma's voclosporin

Bovie Medical seeks FDA marketing approval for 1450RF new high frequency electrosurgical generator

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

Asclera injection receives FDA approval

FDA issues Complete Response Letter for CERTRIAD NDA

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

FDA allows GeoVax Labs to commence phase 1 clinical trial for HIV/AIDS therapeutic vaccine

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Campbell Soup honored for commitment to food allergy safety, awareness and education

Posting calorie counts on menus and menu boards also needed in Ontario

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News